MacroGenics, Inc.
@MacroGenics
Followers
530
Following
24
Media
53
Statuses
231
MacroGenics is discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer.
Rockville, MD
Joined September 2010
RT @tigerlilycares: Dr. Nordstrom’s work in the lab helps research teams learn as much as possible about cancer drugs, like how they work a….
0
1
0
RT @jitcancer: New #JITC review: Role of Fcγ receptors in HER2-targeted breast cancer therapy @a_musolino @hoperugo….
0
7
0
MacroGenics provides update on corporate progress and Q3 2021 financial results
0
0
0
Today is Metastatic Breast Cancer Awareness Day. Visit to learn about the disease that affects thousands of people both today and every day. #MetastaticBreastCancerAwarenessDay.
0
2
1
MacroGenics honors the survivors and those we’ve lost during #BreastCancerAwareness month. We continue our work to increase research around this all-too-common disease.
0
0
1
Excited to announce preliminary clinical results from Ph 1 Cohort Expansion of ongoing MGC018 study at #ESMO21
0
0
0
We are pleased to share our clinical results from Cohort A Pt 1 of Ph 2/3 MAHOGANY study of margetuximab in combination with retifanlimab in gastroesophageal adenocarcinoma at #ESMO21
0
0
1
MacroGenics Announces Final Overall Survival Results from SOPHIA Study of MARGENZA™
0
0
1
RT @BioCentury: On Wednesday, Zai Lab Ltd. entered a deal with @MacroGenics Inc. covering up to four CD3- or CD47-based bispecifics. The ex….
0
1
0
Pleased to Announce Preliminary Clinical Results from Phase 1 Study of MGC018 to be Presented at ASCO Annual Meeting #ASCO21
0
0
0
RT @Genedata: We are happy to announce that @MacroGenics has decided to partner with Genedata to advance their translational and clinical r….
0
1
0
We are excited to announce that Federica O’Brien has joined our Board of Directors. $MGNX Read our announcement here:
0
0
0
SOPHIA trial results have been published in @JAMAOnc; these data describe a new treatment option for adults with metastatic HER2+ breast cancer. Read more here:
0
0
3
Living with metastatic HER2-positive breast cancer and not sure where to turn? Check out the @mbcalliance for information and support services. You can learn from others, share experiences and more:
0
0
1
Scientific advances are bringing women with metastatic HER2-positive #breastcancer the benefits of cutting-edge medical innovations - but there remains unmet need, as patients’ disease progresses. #MBC.
0
0
2
This marks the first FDA approval for MacroGenics – thank you to the patients, physicians, nurses and staff involved in the clinical trial and to our employees who’ve worked to bring important therapies to patients in need.
0
1
13
Today, we announced the FDA approval of a treatment option for patients living with metastatic HER2-positive #breastcancer who have received two or more prior anti-HER2 regimens, at least one of which was for metastatic disease #MBC. Read more:
0
10
18
